{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:34:28Z","timestamp":1764401668101,"version":"3.41.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/inf.0000000000000967","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T12:11:39Z","timestamp":1446639099000},"page":"e60-e64","source":"Crossref","is-referenced-by-count":10,"title":["Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea"],"prefix":"10.1097","volume":"35","author":[{"given":"Dong Soo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwang Cheon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Ho","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo-Han","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwang Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Hong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Han","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joon","family":"Bang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulaikha","family":"Naimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Bouckenooghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Bosch-Castells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy","family":"Houillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-21-20210202","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1016\/j.ijid.2012.02.006","article-title":"Epidemiology of Japanese encephalitis in South Korea, 2007-2010.","volume":"16","author":"Lee","year":"2012","journal-title":"Int J Infect Dis"},{"key":"R2-21-20210202","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1016\/j.vaccine.2008.04.076","article-title":"Long-term stability of Vero cell-derived inactivated Japanese encephalitis vaccine prepared using serum-free medium.","volume":"26","author":"Toriniwa","year":"2008","journal-title":"Vaccine"},{"key":"R3-21-20210202","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1517\/14712598.8.1.95","article-title":"Current use and development of vaccines for Japanese encephalitis.","volume":"8","author":"Beasley","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"R4-21-20210202","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.","volume":"188","author":"Monath","year":"2003","journal-title":"J Infect Dis"},{"key":"R5-21-20210202","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0264-410X(01)00457-1","article-title":"Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections.","volume":"20","author":"Monath","year":"2002","journal-title":"Vaccine"},{"key":"R6-21-20210202","doi-asserted-by":"crossref","first-page":"7993","DOI":"10.1016\/j.vaccine.2010.09.035","article-title":"Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: randomised controlled phase 3 trials.","volume":"28","author":"Torresi","year":"2010","journal-title":"Vaccine"},{"key":"R7-21-20210202","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/INF.0b013e3181f68e9c","article-title":"Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial.","volume":"29","author":"Chokephaibulkit","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"R8-21-20210202","doi-asserted-by":"crossref","first-page":"929","DOI":"10.4161\/hv.20071","article-title":"Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial.","volume":"8","author":"Feroldi","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"R9-21-20210202","doi-asserted-by":"crossref","first-page":"889","DOI":"10.4161\/hv.23087","article-title":"Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children.","volume":"9","author":"Feroldi","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"R10-21-20210202","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.4161\/hv.29743","article-title":"A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.","volume":"10","author":"Kim","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R11-21-20210202","doi-asserted-by":"crossref","first-page":"285","DOI":"10.4049\/jimmunol.99.2.285","article-title":"A plaque reduction test for dengue virus neutralizing antibodies.","volume":"99","author":"Russell","year":"1967","journal-title":"J Immunol"},{"key":"R12-21-20210202","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E","article-title":"Two-sided confidence intervals for the single proportion: comparison of seven methods.","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"R13-21-20210202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3201\/eid0601.000103","article-title":"Japanese encephalitis immunization in South Korea: past, present, and future.","volume":"6","author":"Sohn","year":"2000","journal-title":"Emerg Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000967","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T08:55:56Z","timestamp":1748681756000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201602000-00021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000967","relation":{},"ISSN":["0891-3668"],"issn-type":[{"type":"print","value":"0891-3668"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}